Loading
Simulate how two drugs interact in the body and the tumour to pick a starting dose and schedule, instead of guessing from single-drug data.
Quantitative systems pharmacology models integrate pharmacokinetics, target engagement and downstream biology to predict combination effects and toxicities. FDA's model-informed drug development pathway accepts such models for dose justification. Making a QSP-based schedule proposal a standard component of combination investigational new drug applications would reduce empirical dose-escalation in combinations.
Shares Too many combinations to test, Wrong doses.
Shares AI-driven drug & target discovery, Too many combinations to test.
Shares AI-driven drug & target discovery, Too many combinations to test.
Shares AI-driven drug & target discovery, Too many combinations to test.
Shares AI-driven drug & target discovery, Too many combinations to test.
Shares Too many combinations to test, Wrong doses.
Shares Too many combinations to test, Wrong doses.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/